Therapeutic effects of water soluble Danshen extracts on atherosclerosis

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Cho, Yoon Hee ^a   Ku, Cheol Ryong ^b   Hong, Zhen Yu ^a   Heo, Ji Hoe ^b   Kim, Eun Hee ^b   Choi, Dong Hoon ^b   Kim, Dongkyu ^a   Kim, Ae Jung ^c   Lee, Cheol Soon ^c   Jung, Mankil ^d   Lee, Hyun Chul ^b   Seo, Miran ^a   Lee, Eun Jig ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c EGene Inc   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; PLATELET DERIVED GROWTH FACTOR BB; REACTIVE OXYGEN METABOLITE; SALVIA MILTIORRHIZA EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIATHEROGENIC ACTIVITY; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY BALLOON INJURY; CAROTID ARTERY DISEASE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; EX VIVO STUDY; HUMAN; HUMAN CELL; ILIAC ARTERY STENT; IN VIVO STUDY; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SALVIA MILTIORRHIZA; SMOOTH MUSCLE FIBER; STENT; THROMBOCYTE AGGREGATION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR SMOOTH MUSCLE; VEIN THROMBOSIS;

EID: 84873378251     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/623639     Document Type: Article

References (35)

1. Cheng T. O., Cardiovascular effects of Danshen. International Journal of Cardiology 2007 121 1 9 22 2-s2.0-34548079309 10.1016/j.ijcard.2007.01.004 (Pubitemid 47287779)
2. Zhou L., Zuo Z., Chow M. S. S., Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. Journal of Clinical Pharmacology 2005 45 12 1345 1359 2-s2.0-27844511101 10.1177/0091270005282630 (Pubitemid 41643896)
3. Cheng T. O., Warfarin danshen interaction. Annals of Thoracic Surgery 1999 67 3 894 2-s2.0-0032909970
4. Cheng T. O., Danshen: a popular chinese cardiac herbal drug. Journal of the American College of Cardiology 2006 47 7 1498 1500 2-s2.0-33645402536 10.1016/j.jacc.2006.01.001
5. Cheng T. O., Danshen: what every cardiologist should know about this Chinese herbal drug. International Journal of Cardiology 2006 110 3 411 412 2-s2.0-33744804557 10.1016/j.ijcard.2005.08.069 (Pubitemid 43831220)
6. Han J. Y., Fan J. Y., Horie Y., Miura S., Cui D. H., Ishii H., Hibi T., Tsuneki H., Kimura I., Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacology and Therapeutics 2008 117 2 280 295 2-s2.0-38349123913 10.1016/j.pharmthera.2007.09.008
7. Yagi A., Fujimoto K., Tanonaka K., Hirai K., Takeo S., Possible active components of tan-shen (Salvia miltiorrhiza) for protection of the myocardium against ischemia-induced derangements. Planta Medica 1989 55 1 51 54 2-s2.0-0024502823 (Pubitemid 19058361)
8. Cao J., Qi L. W., Chen J., Yi L., Li P., Ren M. T., Li Y. J., Application of liquid chromatography-electrospray ionization time-of-flight mass spectrometry for analysis and quality control of compound Danshen preparations. Biomedical Chromatography 2009 23 4 397 405 2-s2.0-65249125912 10.1002/bmc.1130
9. Shiao M. S., Chiu J. J., Chang B. W., Wang J., Jen W. P., Wu Y. J., Chen Y. L., In search of antioxidants and anti-atherosclerotic agents from herbal medicines. BioFactors 2008 34 2 147 157 2-s2.0-69549115198 10.1002/biof. 5520340206
10. Lee S., Lim H. J., Park H. Y., Lee K. S., Park J. H., Jang Y., Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model. Atherosclerosis 2006 186 1 29 37 2-s2.0-33646479753 10.1016/j.atherosclerosis.2005.06.048
11. Yan Z. Q., Hansson G. K., Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circulation Research 1998 82 1 21 29 2-s2.0-0031906154 (Pubitemid 28074015)
12. Ohba M., Shibanuma M., Kuroki T., Nose K., Production of hydrogen peroxide by transforming growth factor- β 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. Journal of Cell Biology 1994 126 4 1079 1088 2-s2.0-0028015832 10.1083/jcb.126.4.1079 (Pubitemid 24252152)
13. Jagadeesha D. K., Lindley T. E., DeLeon J., Sharma R. V., Miller F., Bhalla R. C., Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats. American Journal of Physiology 2005 289 3 H1047 H1053 2-s2.0-23944518894 10.1152/ajpheart.01071.2004 (Pubitemid 41208946)
14. Nobukata H., Katsuki Y., Ishikawa T., Inokuma M., Shibutani Y., Effect of dienogest on bleeding time, coagulation, fibrinolysis, and platelet aggregation in female rats. Toxicology Letters 1999 104 1-2 93 101 2-s2.0-0032936151 10.1016/S0378-4274(98)00354-3 (Pubitemid 29048290)
15. Hagimori M., Kamiya S., Yamaguchi Y., Arakawa M., Improving frequency of thrombosis by altering blood flow in the carrageenan-induced rat tail thrombosis model. Pharmacological Research 2009 60 4 320 323 2-s2.0-69249211170 10.1016/j.phrs.2009.04.010
16. Jang H. S., Nam H. Y., Kim J. M., Hahm D. H., Nam S. H., Kim K. L., Joo J. R., Suh W., Park J. S., Kim D. K., Gwon H. C., Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model. Catheterization and Cardiovascular Interventions 2009 74 6 881 888 2-s2.0-73249133992 10.1002/ccd.22047
17. Cao J., Wei Y. J., Qi L. W., Li P., Qian Z. M., Luo H. W., Chen J., Zhao J., Determination of fifteen bioactive components in Radix et Rhizoma Salviae Miltiorrhizae by high-performance liquid chromatography with ultraviolet and mass spectrometric detection. Biomedical Chromatography 2008 22 2 164 172 2-s2.0-39349090988 10.1002/bmc.911 (Pubitemid 351260194)
18. Ross R., The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 362 6423 801 809 2-s2.0-0027241856 10.1038/362801a0 (Pubitemid 23132154)
19. Schwartz S. M., DeBlois D., O'Brien E. R. M., The intima: soil for atherosclerosis and restenosis. Circulation Research 1995 77 3 445 465 2-s2.0-0029098078
20. Kalyanasundaram A., Lincoff A. M., Managing adverse effects and drug-drug interactions of antiplatelet agents. Nature Reviews Cardiology 2011 8 10 592 600
21. Raines E. W., PDGF and cardiovascular disease. Cytokine and Growth Factor Reviews 2004 15 4 237 254 2-s2.0-2942635366 10.1016/j.cytogfr.2004.03.004 (Pubitemid 38781049)
22. Park J., Ha H., Seo J., Kim M. S., Kim H. J., Huh K. H., Park K., Kim Y. S., Mycophenolic acid inhibits platelet-derived growth factor-induced reactive oxygen species and mitogen-activated protein kinase activation in rat vascular smooth muscle cells. American Journal of Transplantation 2004 4 12 1982 1990 2-s2.0-10044232981 10.1111/j.1600-6143.2004.00610.x (Pubitemid 39611625)
23. Sivritas D., Becher M. U., Ebrahimian T., Arfa O., Rapp S., Bohner A., Mueller C. F., Umemura T., Wassmann S., Nickenig G., Wassmann K., Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese superoxide dismutase. Basic Research in Cardiology 2011 106 4 563 575 2-s2.0-79959691138 10.1007/s00395-011-0174-z
24. Kim J. E., Sung J. Y., Woo C. H., Cilostazol inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through activation of AMP-activated protein kinase induced by heme oxygenase-1. Korean Journal of Physiology & Pharmacology 2011 15 4 203 210
25. Gennaro G., Ménard C., Michaud S. É., Deblois D., Rivard A., Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor. Circulation 2004 110 21 3367 3371 2-s2.0-9344223972 10.1161/01.CIR.0000147773.86866.CD (Pubitemid 39557501)
26. Pober J. S., Cotran R. S., Cytokines and endothelial cell biology. Physiological Reviews 1990 70 2 427 451 2-s2.0-0025304016 (Pubitemid 20140187)
27. Wong C. K., Tsang C. M., Ip W. K., Lam C. W. K., Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF: roles of ERK, p38 MAPK, and NF- B. Allergy 2006 61 3 289 297 2-s2.0-33644980666 10.1111/j.1398-9995.2006.00972.x
28. Jackson S. P., Nesbitt W. S., Kulkarni S., Signaling events underlying thrombus formation. Journal of Thrombosis and Haemostasis 2003 1 7 1602 1612 2-s2.0-0141721540
29. Hagimori M., Kamiya S., Yamaguchi Y., Arakawa M., Improving frequency of thrombosis by altering blood flow in the carrageenan-induced rat tail thrombosis model. Pharmacological Research 2009 60 4 320 323 2-s2.0-69249211170 10.1016/j.phrs.2009.04.010
30. Nakazawa G., Finn A. V., Ladich E., Ribichini F., Coleman L., Kolodgie F. D., Virmani R., Drug-eluting stent safety: Findings from preclinical studies. Expert Review of Cardiovascular Therapy 2008 6 10 1379 1391 2-s2.0-59049099699 10.1586/14779072.6.10.1379
31. Zhou L., Zuo Z., Chow M. S. S., Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. Journal of Clinical Pharmacology 2005 45 12 1345 1359 2-s2.0-27844511101 10.1177/0091270005282630 (Pubitemid 41643896)
32. Steinkamp-Fenske K., Bollinger L., Völler N., Xu H., Yao Y., Bauer R., Förstermann U., Li H., Ursolic acid from the Chinese herb Danshen (Salvia miltiorrhiza L.) upregulates eNOS and downregulates Nox4 expression in human endothelial cells. Atherosclerosis 2007 195 1 e104 e111 2-s2.0-35248872474 10.1016/j.atherosclerosis.2007.03.028 (Pubitemid 47561965)
33. Chen L., Wang W. Y., Wang Y. P., Inhibitory effects of lithospermic acid on proliferation and migration of rat vascular smooth muscle cells. Acta Pharmacologica Sinica 2009 30 9 1245 1252 2-s2.0-70249131461 10.1038/aps.2009.122
34. Moon C. Y., Ku C. R., Cho Y. H., Lee E. J., Protocatechuic aldehyde inhibits migration and proliferation of vascular smooth muscle cells and intravascular thrombosis. Biochemical and Biophysical Research Communications 2012 423 1 116 121
35. Fan H. Y., Fu F. H., Yang M. Y., Xu H., Zhang A. H., Liu K., Antiplatelet and antithrombotic activities of salvianolic acid A. Thrombosis Research 2010 126 1 e17 e22 2-s2.0-77953120701 10.1016/j.thromres.2010.04.006